Avastus Preclinical Services

Executive Summary

Avastus Preclinical Services, founded in 2018 and based in San Diego, is a contract research organization (CRO) specializing in preclinical and vivarium services. The company offers regulatory-compliant in vivo studies, vivarium space rental, and full facility management to pharmaceutical and biotechnology clients. By providing these services, Avastus enables its customers to reduce infrastructure costs and extend their operational runway during drug development. The company's focus on both small molecules and biologics positions it to serve a broad range of preclinical needs in a competitive CRO market. Avastus is privately held and operates at the pre-clinical stage, with no disclosed funding or valuation. As a service provider, its growth is tied to the expansion of its client base and the capacity of its facilities. Given the increasing demand for outsourced preclinical services in the San Diego biotech hub, Avastus has opportunities to scale. However, limited public information makes it challenging to assess its financial performance or competitive edge. The company's success will depend on securing recurring contracts, maintaining high-quality standards, and potentially expanding its facility footprint.

Upcoming Catalysts (preview)

• 2026New Large-Capacity Vivarium Expansion50% success
• 2026Strategic Partnership with Mid-Sized Pharma40% success
• TBDAAALAC Accreditation or Regulatory Milestone60% success